Skip to content

Cash ratio at other companies

Eli Lilly logo
Eli LillyLLY
0.1×0.0×
Pfizer logo
PfizerPFE
0.1×0.0×
Rogers Corporation logo
Rogers CorporationROG
1.5×+0.2×
Amgen logo
AmgenAMGN
0.0×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.6×-0.3×
Incyte logo
IncyteINCY
2.3×+1.2×

Other financials

Income statement

See full
Revenue$15.0K-97.8%
Operating income-$84.4M-34.6%
Net income-$78.7M-46.3%
EPS (diluted)-$1.18-45.7%

Balance sheet

See full
Cash & equivalents$35.7M+109%
Total debt$1.9M-44.3%
Total equity$456.2M-35.1%
Total assets$511.3M-30.9%

Cash flow

See full
Operating cash flow-$65.6M-20.6%
CapEx$1.6M+518%
Free cash flow-$67.2M-23.0%

Valuation

See full
Market cap$2.59B+75.2%
Enterprise value$2.55B+74.4%
P/S2,989.2×+2,794×

Profitability

See full
Operating margin-35,688.5%-39,114pp
Net margin-32,753.6%-35,519pp
FCF margin-26,125.8%-28,907pp

Returns & leverage

See full
Return on equity-48.9%-498pp
Debt / equity0.0×
Current ratio8.9×-12.7×

Where this comes from

Calculated from Celldex Therapeutics’s reported figures.

Based on the most recent quarter.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celldex Therapeutics's cash ratio?
Celldex Therapeutics (CLDX) reported cash ratio of 0.7× in Q1 2026.
How has Celldex Therapeutics's cash ratio changed year-over-year?
Celldex Therapeutics's cash ratio increased by 29.7% year-over-year, from 0.5× to 0.7×.
What is the long-term trend for Celldex Therapeutics's cash ratio?
Over 5 years (2020 to 2025), Celldex Therapeutics's cash ratio has grown at a -28.8% compound annual growth rate (CAGR), from 3.1× to 0.6×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.